These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 25515952

  • 21. Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients.
    Anand A, Trägårdh E, Edenbrandt L, Beckman L, Svensson JH, Thellenberg C, Widmark A, Kindblom J, Ullén A, Bjartell A.
    J Nucl Med; 2020 May; 61(5):671-675. PubMed ID: 31586004
    [Abstract] [Full Text] [Related]

  • 22. Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases.
    Wei RJ, Li TY, Yang XC, Jia N, Yang XL, Song HB.
    Genet Mol Res; 2016 Jun 03; 15(2):. PubMed ID: 27323113
    [Abstract] [Full Text] [Related]

  • 23. Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma.
    Amico S, Liehn JC, Desoize B, Larbre H, Deltour G, Valeyre J.
    Clin Nucl Med; 1991 Sep 03; 16(9):643-8. PubMed ID: 1718651
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary.
    Küronya Z, Sinkovics I, Ágoston P, Bíró K, Bodrogi I, Böde I, Dank M, Gyergyay F, Vajdics T, Kolonics Z, Nagyiványi K, Rúzsa Á, Géczi L.
    Pathol Oncol Res; 2017 Oct 03; 23(4):777-783. PubMed ID: 28074331
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pretreatment PSA levels affects the completion rate of Ra-223 treatment.
    Utsumi N, Kurosaki H, Miura K, Kitoh H, Akakura K.
    Sci Rep; 2021 Mar 19; 11(1):6476. PubMed ID: 33742050
    [Abstract] [Full Text] [Related]

  • 31. Prostate-Specific Antigen Flare Phenomenon During 223Ra-Dichloride Treatment for Bone Metastatic Castration-Resistant Prostate Cancer: A Case Report.
    De Vincentis G, Follacchio GA, Frantellizzi V, Liberatore M, Monteleone F, Cortesi E.
    Clin Genitourin Cancer; 2016 Oct 19; 14(5):e529-e533. PubMed ID: 27212044
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Radium-223 for men with hormone-refractory prostate cancer and bone metastases.
    Shelley MD, Mason MD.
    Lancet Oncol; 2007 Jul 19; 8(7):564-5. PubMed ID: 17613416
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Complete Cycles of Radium-223 Improve Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study.
    Yang HC, Chang LW, Li JR, Wang SS, Yang CK, Chen CS, Lu K, Chen CC, Wang SC, Lin CY, Cheng CL, Ou YC, Chiu KY, Hung SC.
    Anticancer Res; 2023 Apr 19; 43(4):1809-1816. PubMed ID: 36974814
    [Abstract] [Full Text] [Related]

  • 36. Bone scan index can be a useful biomarker of survival outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223.
    Naito M, Ukai R, Hashimoto K.
    Cancer Rep (Hoboken); 2019 Oct 19; 2(5):e1203. PubMed ID: 32721117
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.